Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > The cost of the machine
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Comment by TanzaniteMotherLodeon Aug 08, 2020 10:58am
69 Views
Post# 31382613

RE:RE:RE:RE:RE:RE: The cost of the machine

RE:RE:RE:RE:RE:RE: The cost of the machineIt's obvious that Joe Biden in his basement (aka Tony on the Yahoo messages board) does not appreciate this disruptive technology as he is a representative from another company.  He is not a shareholder of this stock (no shareholder would speak this way) and will have much to lose when this commercial launch occurs.  He is trying to gather commercial information for competitive reasons,  (that's why he is p!ssed off with management cause he is trying to get info but they aren't giving it to him)

This analysis of TONY is accurate and you can take it to the bank.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities